Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bey

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Bulletin Du Cancer|July 19, 2001
[Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology]B Fervers, P Bey, D Maigne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 16, 2002
[Conformal radiotherapy in prostate cancer: for whom and how?]P Bey, V Beckendorf, P Aletti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1995
Detection of errors in individual patients in radiotherapy by systematic in vivo dosimetryA Noel, P Aletti, P Bey, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1981
[Carcinoma of a nasopharynx. Apropos of 42 cases treated between 1968 and 1977]P Bey, B Gueddari, L Malissard, et al.
Biochemical Pharmacology|December 1, 1982
alpha-Monofluoromethyl and alpha-difluoromethyl putrescine as ornithine decarboxylase inhibitors: in vitro and in vivo biochemical propertiesC Danzin, P Bey, D Schirlin, et al.
Annales De Medecine Interne|January 1, 1971
[Isolation muscular sarcoidosis of tumoral form]A Larcan, O Guerci, J Floquet, et al.
European Journal of Cancer|April 1, 1977
Anaplastic carcinoma of the thyroid glandP Schoumacher, R Metz, P Bey, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Pediatric tumorsD Olive, E Benz-Lemoine, P Bey, et al.
Life Sciences|February 5, 1979
Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissuesC Danzin, M J Jung, J Grove, et al.
Journal of Medicinal Chemistry|November 1, 1983
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylaseP Bey, F Gerhart, V Van Dorsselaer, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Bulletin Du Cancer|July 19, 2001
[Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology]B Fervers, P Bey, D Maigne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 16, 2002
[Conformal radiotherapy in prostate cancer: for whom and how?]P Bey, V Beckendorf, P Aletti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1995
Detection of errors in individual patients in radiotherapy by systematic in vivo dosimetryA Noel, P Aletti, P Bey, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1981
[Carcinoma of a nasopharynx. Apropos of 42 cases treated between 1968 and 1977]P Bey, B Gueddari, L Malissard, et al.
Biochemical Pharmacology|December 1, 1982
alpha-Monofluoromethyl and alpha-difluoromethyl putrescine as ornithine decarboxylase inhibitors: in vitro and in vivo biochemical propertiesC Danzin, P Bey, D Schirlin, et al.
Annales De Medecine Interne|January 1, 1971
[Isolation muscular sarcoidosis of tumoral form]A Larcan, O Guerci, J Floquet, et al.
European Journal of Cancer|April 1, 1977
Anaplastic carcinoma of the thyroid glandP Schoumacher, R Metz, P Bey, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Pediatric tumorsD Olive, E Benz-Lemoine, P Bey, et al.
Life Sciences|February 5, 1979
Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissuesC Danzin, M J Jung, J Grove, et al.
Journal of Medicinal Chemistry|November 1, 1983
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylaseP Bey, F Gerhart, V Van Dorsselaer, et al.
Pageof 18